Halozyme Therapeutics
HALO
#2120
Rank
A$11.25 B
Marketcap
$88.85
Share price
-0.44%
Change (1 day)
44.03%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: A$11.25 Billion

As of September 2024 Halozyme Therapeutics has a market cap of A$11.25 Billion. This makes Halozyme Therapeutics the world's 2120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024A$11.25 B57.07%
2023A$7.16 B-36.61%
2022A$11.30 B45.21%
2021A$7.78 B3.91%
2020A$7.49 B117.3%
2019A$3.44 B14.77%
2018A$3.00 B-18.67%
2017A$3.69 B108.15%
2016A$1.77 B-41.79%
2015A$3.04 B106.08%
2014A$1.47 B-23.14%
2013A$1.92 B163.88%
2012A$0.72 B-24.15%
2011A$0.96 B22.23%
2010A$0.78 B30.76%
2009A$0.60 B-8.88%
2008A$0.66 B4.18%
2007A$0.63 B-9.69%
2006A$0.70 B368.4%
2005A$0.14 B7.13%
2004A$0.13 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Halozyme Therapeutics was reported to be:

A$11.25 Billion
by Yahoo Finance info icon info icon
A$11.25 Billion
by CompaniesMarketCap info icon info icon
A$11.25 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
A$2.72 B-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.244 T 10,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.45 B 161.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$250.05 B 2,121.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$216.68 B 1,825.15%๐Ÿ‡ซ๐Ÿ‡ท France
A$592.71 B 5,165.87%๐Ÿ‡บ๐Ÿ‡ธ USA